Gastrointestinal microflora and interactions with gut mucosa

Handbook of Prebiotics

Volumn , Issue , 2008, Pages 32-57

  Wells, Andrew L ^a   Saulnier, Delphind M A ^a   Gibson, Glenn R ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056065005     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (135)

1. Stainier, D. Y. R., No organ left behind: Tales of gut development and evolution. Science 2005, 307(5717), 1902-1904.
2. Bjorksten, B., The gut microbiota: A complex ecosystem. Clinical and Experimental Allergy 2006, 36(10), 1215-1217.
3. Boyle, R. J., Tang, M. L. K., The role of probiotics in the management of allergic disease. Clinical and Experimental Allergy 2006, 36(5), 568-576.
4. Holzapfel, W. H., Haberer, P., Snel, J., Schillinger, U., Huis in't Veld, J. H. J., Overview of gut flora and probiotics. International Journal of Food Microbiology1998,41(2), 85-101.
5. Stephen, A. M., Cummings, J. H., Microbial contribution to human fecal mass. Journal of Medical Microbiology 1980, 13(1), 45-56.
6. Backhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., Gordon, J. I., Host-bacterial mutualism in the human intestine. Science 2005, 307(5717), 1915-1920.
7. Moore, W. E. C., Holdeman, L. V., Human fecal flora—Normal flora of 20 Japanese-Hawaiians. Applied Microbiology 1974, 27(5), 961-979.
8. Guarner, F., Malagelada, J. R., Gut flora in health and disease. Lancet 2003, 361(9356), 512-519.
9. Marteau, P., Pochart, P., Dore, J., Bera-Maillet, C., Bernalier, A., Corthier, G., Comparative study of bacterial groups within the human cecal and fecal microbiota. Applied and Environmental Microbiology 2001, 67(10), 4939-4942.
10. Cummings, J. H., Beatty, E. R., Kingman, S. M., Bingham, S. A., Englyst, H. N., Digestion and physiological properties of resistant starch in the human large bowel. British Journal of Nutrition 1996, 75(5), 733-747.
11. Cummings, J. H., Pomare, E. W., Branch, W. J., Naylor, C. P. E., Macfarlane, G. T., Short chain fatty-acids in human large-intestine, portal, hepatic and venous-blood. Gut 1987, 28(10), 1221-1227.
12. Macfarlane, G. T., Cummings, J. H., Allison, C., Protein-degradation by human intestinal bacteria. Journal of General Microbiology 1986, 132,1647-1656.
13. Macfarlane, G. T., Gibson, G. R., Cummings, J. H., Comparison of fermentation reactions in different regions of the human colon. Journal of Applied Bacteriology1992, 72(1), 57-64.
14. Younes, H., Coudray, C., Bellanger, J., Demigne, C., Rayssiguier, Y., Remesy, C., Effects of two fermentable carbohydrates (inulin and resistant starch) and their combination on calcium and magnesium balance in rats. British Journal of Nutrition 2001, 86(4), 479-485.
15. Roberfroid, M. B., Bornet, F., Bouley, C., Cummings, J. H., Colonic microflora— nutrition and health—Summary and conclusions of an international life sciences institute (Ilsi) [Europe] workshop held in Barcelona, Spain. Nutrition Reviews1995, 53(5), 127-130.
16. Elsen, R. J., Bistrian, B. R., Recent developments in short-chain fatty-acid metabolism. Nutrition 1991, 7(1), 7-10.
17. Rosenfeldt, V., Benfeldt, E., Valerius, N. H., Paerregaard, A., Michaelsen, K. F., Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. Journal of Pediatrics 2004, 145(5), 612-616.
18. Marteau, P., Boutron-Ruault, M. C., Nutritional advantages of probiotics and prebiotics. British Journal of Nutrition 2002, 87, S153-S157.
19. Hill, M. J., Intestinal flora and endogenous vitamin synthesis. European Journal of Cancer Prevention 1997, 6, S43-S45.
20. Conly, J. M., Stein, K., Worobetz, L., Rutledgeharding, S., The contribution of vitamin-K-2 (menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin-K. American Journal of Gastroenterology1994, 89(6), 915-923.
21. Taguchi, H., Takahashi, M., Yamaguchi, H., Osaki, T., Komatsu, A., Fujioka, Y., Kamiya, S., Experimental infection of germ-free mice with hyper-toxigenic enterohaemorrhagic Escherichia coli O157:H7, strain 6. Journal of Medical Microbiology 2002, 51(4), 336-343.
22. Baba, E., Nagaishi, S., Fukata, T., Arakawa, A., The role of intestinal microflora on the prevention of Salmonella colonization in gnotobiotic chickens. Poultry Science 1991, 70(9), 1902-1907.
23. Saito, T., Selection of useful probiotic lactic acid bacteria from the Lactobacillus acidophilus group and their applications to functional foods. Animal Science Journal 2004, 75(1), 47-50.
24. Ouwehand, A. C., Salminen, S., In vitro adhesion assays for probiotics and their in vivo relevance: A review. Microbial Ecological in Health Disease 2003, 15, 175-184.
25. Dunne, C., O'Mahony, L., Murphy, L., Thornton, G., Morrissey, D., O'Halloran, S., Feeney, M. et al., In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. American Journal of Clinical Nutrition2001, 73(2), 386S-392S.
26. Hooper, L. V., Xu, J., Falk, P. G., Midtvedt, T., Gordon, J. I., A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. PNAS 1999, 96(17), 9833-9838.
27. Oh, S., Kim, S. H., Worobo, R. W., Characterization and purification of a bac-teriocin produced by a potential probiotic culture, Lactobacillus acidophilus 30SC. Journal of Dairy Science 2000, 83(12), 2747-2752.
28. Hancock, R. E. W., Lehrer, R., Cationic peptides: A new source of antibiotics. Trends in Biotechnology 1998,16 (2), 82-88.
29. van Belkum, M. J., Stiles, M. E., Nonlantibiotic antibacterial peptides from lactic acid bacteria. Natural Product Reports 2000, 17(4), 323-335.
30. Lavermicocca, P., Valerio, F., Evidente, A., Lazzaroni, S., Corsetti, A., Gob-betti, M., Purification and characterization of novel antifungal compounds from the sourdough Lactobacillus plantarum strain 21B. Applied and Environmental Microbiology 2000, 66(9), 4084-4090.
31. Messens, W., De Vuyst, L., Inhibitory substances produced by lactobacilli isolated from sourdoughs—A review. International Journal of Food Microbiology 2002, 72(1-2), 31-43.
32. Tagg, J. R., Dajani, A. S., Wannamaker, L. W., Bacteriocins of Gram-positive bacteria. Bacteriological Reviews 1976, 40(3), 722-756.
33. Jack, R. W., Tagg, J. R., Ray, B., Bacteriocins of Gram-positive bacteria. Microbiological Reviews 1995, 59(2), 171-200.
34. Abee, T., Krockel, L., Hill, C., Bacteriocins: Modes of action and potentials in food preservation and control of food poisoning. International Journal of Food Microbiology 1995, 28(2), 169-185.
35. Matijasic, B. B., Rogelj, I., Bacteriocinogenic activity of lactobacilli isolated from cheese and baby faeces. Food Technology and Biotechnology 1999, 37(2), 93-100.
36. Kawai, Y., Saito, T., Uemura, J., Itoh, T., Rapid detection method for bacteri-ocin and distribution of bacteriocin-producing strains in Lactobacillus acidophilus group lactic acid bacteria isolated from human feces. Bioscience Biotechnology and Biochemistry 1997, 61(1), 179-182.
37. Papagianni, M., Avramidis, N., Filioussis, G., Dasiou, D., Ambrosiadis, I., Determination of bacteriocin activity with bioassays carried out on solid and liquid substrates: Assessing the factor "indicator microorganism." Microbial Cell Factories 2006, 5, 30.
38. Umesaki, Y., Setoyama, H., Matsumoto, S., Okada, Y., Expansion of alpha-beta T-cell receptor-bearing intestinal intraepithelial lymphocytes after microbial colonization in germ-free mice and its independence from thymus. Immunology1993, 79(1), 32-37.
39. Isolauri, E., Sutas, Y., Kankaanpaa, P., Arvilommi, H., Salminen, S., Probiotics: Effects on immunity. American Journal of Clinical Nutrition 2001, 73(2), 444S-450S.
40. Simon, G. L., Gorbach, S. L., Intestinal flora in health and disease. Gastroenterology 1984, 86(1), 174-193.
41. Adlerberth, I., Carlsson, B., Deman, P., Jalil, F., Khan, S. R., Larsson, P., Mellander, L., Svanborg, C., Wold, A. E., Hanson, L. A., Intestinal colonization with Enterobacteriaceae in Pakistani and Swedish hospital-delivered infants. Acta Paediatrica Scandinavica 1991, 80(6-7), 602-610.
42. Lundequist, B., Nord, C. E., Winberg, J., The composition of the fecal microflora in breastfed and bottle fed infants from birth to 8 weeks. Acta Paediatrica Scandinavica 1985, 74(1), 45-51.
43. Santosa, S., Farnworth, E., Jones, P. J. H., Probiotics and their potential health claims. Nutrition Reviews 2006, 64(6), 265-274.
44. Simhon, A., Douglas, J. R., Drasar, B. S., Soothill, J. F., Effect of feeding on infants fecal flora. Archives of Disease in Childhood 1982, 57(1), 54-58.
45. Mombelli, B., Gismondo, M. R., The use of probiotics in medical practice. International Journal of Antimicrobial Agents 2000,16(4), 531-536.
46. Stanton, C., Gardiner, G., Meehan, H., Collins, K., Fitzgerald, G., Lynch, P. B., Ross, R. P., Market potential for probiotics. American Journal of Clinical Nutrition2001, 73(2), 476S-483S.
47. Boyle, R. J., Robins-Browne, R. M., Tang, M. L. K., Probiotic use in clinical practice: what are the risks? American Journal of Clinical Nutrition 2006, 83(6), 1256-1264.
48. Senok, A. C., Ismaeel, A. Y., Botta, G. A., Probiotics: Facts and myths. Clinical Microbiology and Infection 2005,11(12), 958-966.
49. Lilly, D. M., Stillwell, R. H., Probiotics: Growth-promoting factors produced by microorganisms. Science 1965, 147(3659), 747-748.
50. Fuller, R., Probiotics in man and animals. Journal of Applied Bacteriology 1989, 66(5), 365-378.
51. Salminen, S., Ouwehand, A., Benno, Y., Lee, Y. K., Probiotics: How should they be defined? Trends in Food Science & Technology 1999,10(3), 107-110.
52. Sepp, E., Mikelsaar, M., Salminen, S., Effect of administration of Lactobacillus casei strain GG on the gastrointestinal microbiota of newborns. Microbial Ecology in Health and Disease 1993, 6(6), 309-314.
53. Fujisawa, T., Benno, Y., Yaeshima, T., Mitsuoka, T., Taxonomic study of the Lactobacillus acidophilus group, with recognition of Lactobacillus gallinarum sp-nov and Lactobacillus johnsonii sp-nov and synonymy of Lactobacillus acidophilus Group-A3 (Johnson et al., 1980) with the type strain of Lactobacillus amylovorus (Nakamura, 1981). International Journal of Systematic Bacteriology 1992, 42(3), 487-491.
54. Johnson, J. L., Phelps, C. F., Cummins, C. S., London, J., Gasser, F., Taxonomy of the Lactobacillus acidophilus group. International Journal of Systematic Bacteriology1980, 30(1), 53-68.
55. Mueller, S., Saunier, K., Hanisch, C., Norin, E., Alm, L., Midtvedt, T., Cresci, A. et al., Differences in fecal microbiota in different European study populations in relation to age, gender, and country: A cross-sectional study. Applied and Environmental Microbiology 2006, 72(2), 1027-1033.
56. Ventura, M., van Sinderen, D., Fitzgerald, G. F., Zink, R., Insights into the taxonomy, genetics and physiology of bifidobacteria. Antonie Van Leeuwenhoek International Journal of General and Molecular Microbiology 2004, 86(3), 205-223.
57. Lauer, E., Kandler, O., DNA-DNA homology, murein types and enzyme patterns in the type strains of the genus Bifidobacterium. Systematic and Applied Microbiology 1983, 4(1), 42-64.
58. Collins, M. D., Gibson, G. R., Probiotics, prebiotics, and synbiotics: Approaches for modulating the microbial ecology of the gut. American Journal of Clinical Nutrition 1999, 69(5), 1052S-1057S.
59. Gibson, G. R., Roberfroid, M. B., Dietary modulation of the human colonic microbiota—Introducing the concept of prebiotics. Journal of Nutrition 1995, 125(6), 1401-1412.
60. Gibson, G. R., Probert, H. M., Van Loo, J., Rastall, R. A., Roberfroid, M. B., Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics. Nutrition Research Reviews 2004, 17(2), 259-275.
61. Salminen, S., Bouley, C., Boutron-Ruault, M. C., Cummings, J. H., Franck, A., Gibson, G. R., Isolauri, E., Moreau, M. C., Roberfroid, M., Rowland, I., Functional food science and gastrointestinal physiology and function. British Journal of Nutrition 1998, 80, S147-S171.
62. Frost and Sullivan European Probiotic and Prebiotic Functional Food Market, 2000.
63. Gibson, G. R., Wang, X., Enrichment of bifidobacteria from human gut contents by oligofructose using continuous-culture. FEMS Microbiology Letters 1994, 118(1-2), 121-127.
64. Wang, X., Gibson, G. R., Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. Journal of Applied Bacteriology 1993, 75(4), 373-380.
65. Probert, H. M., Gibson, G. R., Investigating the prebiotic and gas-generating effects of selected carbohydrates on the human colonic microflora. Letters in Applied Microbiology 2002, 35(6), 473-480.
66. Kolida, S., Tuohy, K., Gibson, G. R., Prebiotic effects of inulin and oligofructose. British Journal of Nutrition 2002, 87, S193-S197.
67. Macfarlane, S., Macfarlane, G. T., Cummings, J. H., Review article: Prebiotics in the gastrointestinal tract. Alimentary Pharmacology & Therapeutics 2006, 24, 701-714.
68. Langlands, S. J., Hopkins, M. J., Coleman, N., Cummings, J. H., Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut 2004, 53(11), 1610-1616.
69. Reddy, B. S., Prevention of colon cancer by pre- and probiotics: Evidence from laboratory studies. British Journal of Nutrition 1998, 80(4), S219-S223.
70. Reddy, B. S., Possible mechanisms by which pro- and prebiotics influence colon carcinogenesis and tumor growth. Journal of Nutrition 1999,129(7), 1478S-1482S.
71. Rowland, I. R., Rumney, C. J., Coutts, J. T., Lievense, L. C., Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 1998,19(2), 281-285.
72. Rafter, J., Bennett, M., Caderni, G., Clune, Y., Hughes, R., Karlsson, P. C., Klinder, A. et al., Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. American Journal of Clinical Nutrition 2007, 82(2), 488-496.
73. Cummings, J. H., Macfarlane, G. T., Role of intestinal bacteria in nutrient metabolism. Clinical Nutrition 1997, 16(1), 3-11.
74. Zopf, D., Roth, S., Oligosaccharide anti-infective agents. Lancet 1996, 347, 1017-1021.
75. Schrezenmeir, J., de Vrese, M., Probiotics, prebiotics, and synbiotics— Approaching a definition. American Journal of Clinical Nutrition 2001, 73 (Suppl.), 361S-364S.
76. Asahara, T., Nomoto, K., Shimizu, K., Watanuki, M., Tanaka, R., Increased resistance of mice to Salmonella enterica serovar Typhimurium infection by synbi-otic administration of bifidobacteria and transgalactosylated oligosaccharides. Journal of Applied Microbiology 2001, 91(6), 985-996.
77. Wang, X., Brown, I. L., Evans, A. J., Conway, P. L., The protective effects of high amylose maize (amylomaize) starch granules on the survival of Bifidobacterium spp. in the mouse intestinal tract. Journal of Applied Microbiology 1999, 87(5), 631-639.
78. Van Loo, J., Clune, Y., Bennett, M., Collins, J. K., The SYNCAN project: Goals, set-up, first results and settings of the human intervention study. British Journal of Nutrition 2005, 93(Suppl. 1), S91-S98.
79. Roller, M., Clune, Y., Collins, K., Rechkemmer, G., Watzl, B., Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients. British Journal of Nutrition, 2007, 97(4), 676-684.
80. Ofek, I., Hasty, D. L., Sharon, N., Anti-adhesion therapy of bacterial diseases: Prospects and problems. FEMS Immunology and Medical Microbiology 2003,38(3), 181-191.
81. Sharon, N., Carbohydrates as future anti-adhesion drugs for infectious diseases. Biochimica Et Biophysica Acta-General Subjects 2006, 1760(4), 527-537.
82. Kontiokari, T., Sundqvist, K., Nuutinen, M., Pokka, T., Koskela, M., Uhari, M., Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. British Medical Journal 2001, 322(7302), 1571-1573.
83. Rhoades, J., Gibson, G., Formentin, K., Beer, M., Rastall, R., Inhibition of the adhesion of enteropathogenic Escherichia coli strains to HT-29 cells in culture by chito-oligosaccharides. Carbohydrate Polymers 2006, 64(1), 57-59.
84. Zopf, D., Roth, S., Oligosaccharide anti-infective agents. The Lancet 1996, 347(9007), 1017-1021.
85. Firon, N., Ashkenazi, S., Mirelman, D., Ofek, I., Sharon, N., Aromatic alpha-glycosides of mannose are powerful inhibitors of the adherence of type-1 fimbriated Escherichia coli to yeast and intestinal epithelial cells. Infection and Immunity 1987, 55(2), 472-476.
86. Lindhorst, T. K., Kotter, S., Kubisch, J., Krallmann-Wenzel, U., Ehlers, S., Kren, V., Effect of p-substitution of aryl alpha-D-mannosides on inhibiting mannose-sensitive adhesion of Escherichia coli—Syntheses and testing. European Journal of Organic Chemistry 1998, 8, 1669-1674.
87. Simon, P. M., Pharmaceutical oligosaccharides. Drug Discovery Today 1996,1(12), 522-528.
88. Boas, U., Heegaard, P. M. H., Dendrimers in drug research. Chemical Society Reviews 2004, 33(1), 43-63.
89. Turnbull, W. B., Stoddart, J. F., Design and synthesis of glycodendrimers. Reviews in Molecular Biotechnology 2002, 90(3-4), 231-255.
90. Bezouska, K., Design, functional evaluation and biomedical applications of carbohydrate dendrimers (glycodendrimers). Reviews in Molecular Biotechnology2002, 90(3-4), 269-290.
91. Alper, J., Searching for medicine's sweet spot. Science 2001, 291(5512), 2338-2343.
92. Mammen, M., Choi, S. K., Whitesides, G. M., Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angewandte Chemie-International Edition 1998, 37(20), 2755-2794.
93. Sanderson, I. R., Walker, W. A., Uptake and transport of macromolecules by the intestine—Possible role in clinical disorders (an update). Gastroenterology 1993, 104 (2), 622-639.
94. Pelto, L., Isolauri, E., Lilius, E. M., Nuutila, J., Salminen, S., Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clinical & Experimental Allergy 1998, 28(12), 1474-1479.
95. Schiffrin, E. J., Rochat, F., Linkamster, H., Aeschlimann, J. M., Donnethughes, A., Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. Journal of Dairy Science 1995, 78(3), 491-497.
96. Muscettola, M., Massai, L., Tanganelli, C., Grasso, G., Effects of lactobacilli on interferon production in young and aged mice. In Pharmacology of Aging Processes: Methods of Assessment and Potential Interventions, 1994, 717, 226-232.
97. Gill, H. S., Rutherfurd, K. J., Cross, M. L., Gopal, P. K., Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. American Journal of Clinical Nutrition 2001, 74(6), 833-839.
98. Gill, H. S., Cross, M. L., Rutherfurd, K. J., Gopal, P. K., Dietary probiotic supplementation to enhance cellular immunity in the elderly. British Journal of Biomedical Science 2001, 58(2), 94-96.
99. Holzapfel, W. H., Haberer, P., Geisen, R., Bjorkroth, J., Schillinger, U., Taxonomy and important features of probiotic microorganisms in food and nutrition. American Journal of Clinical Nutrition 2001, 73(2), 365S-373S.
100. Cross, M. L., Mortensen, R. R., Kudsk, J., Gill, H. S., Dietary intake of Lactobacillus rhamnosus HN001 enhances production of both Th1 and Th2 cytokines in antigen-primed mice. Medical Microbiology and Immunology 2002,191(1), 49-53.
101. Madsen, K., Cornish, A., Soper, P., McKaigney, C., Jijon, H., Yachimec, C., Doyle, J., Jewell, L., De Simone, C., Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001, 121(3), 580-591.
102. Matsuzaki, T., Chin, J., Modulating immune responses with probiotic bacteria. Immunology and Cell Biology 2000, 78(1), 67-73.
103. Matsuzaki, T., Yamazaki, R., Hashimoto, S., Yokokura, T., The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice. Journal of Dairy Science 1998, 81(1), 48-53.
104. Mack, D. R., Lebel, S., Role of probioticsin the modulation of intestinal infections and inflammation. Current Opinion in Gastroenterology 2004,20(1), 22-26.
105. Miettinen, M., Lehtonen, A., Julkunen, I., Matikainen, S., Lactobacilli and streptococci activate NF-kappa B and STAT signaling pathways in human macrophages. Journal of Immunology 2000, 164(7), 3733-3740.
106. Perdigon, G., Vintini, E., Alvarez, S., Medina, M., Medici, M., Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria. Journal of Dairy Science 1999, 82(6), 1108-1114.
107. Fukushima, Y., Kawata, Y., Hara, H., Terada, A., Mitsuoka, T., Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. International Journal of Food Microbiology 1998,42(1-2), 39-44.
108. Kaila, M., Isolauri, E., Soppi, E., Virtanen, E., Laine, S., Arvilommi, H., Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatric Research 1992, 32(2), 141-144.
109. Drakes, M., Blanchard, T., Czinn, S., Bacterial probiotic modulation of dendritic cells. Infection and Immunity 2004, 72(6), 3299-3309.
110. Marteau, P., Seksik, P., Lepage, P., Dore, J., Cellular and physiological effects of probiotics and prebiotics. Mini-Reviews in Medicinal Chemistry 2004, 4(8), 889-896.
111. Zhou, J. S., Gopal, P. K., Gill, H. S., Potential probiotic lactic acid bacteria Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) do not degrade gastric mucin in vitro. International Journal of Food Microbiology 2001, 63(1-2), 81-90.
112. Mack, D. R., Michail, S., Wei, S., McDougall, L., Hollingsworth, M. A., Probiotics inhibit enteropathogenic E-coli adherence in vitro by inducing intestinal mucin gene expression. American Journal of Physiology, Gastrointestinal and Liver Physiology 1999, 276(4), G941-G950.
113. Ling, W. H., Korpela, R., Mykkanen, H., Salminen, S., Hanninen, O., Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. Journal of Nutrition 1994, 124(1), 18-23.
114. Spanhaak, S., Havenaar, R., Schaafsma, G., The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. European Journal of Clinical Nutrition 1998, 52(12), 899-907.
115. Gluck, U., Gebbers, J. O., Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci). American Journal of Clinical Nutrition 2003, 77(2), 517-520.
116. Hatakka, K., Savilahti, E., Ponka, A., Meurman, J. H., Poussa, T., Nase, L., Saxelin, M., Korpela, R., Effect of long term consumption of probiotic milk on infections in children attending day care centres: Double blind, randomised trial. British Medical Journal 2001, 322(7298), 1327-1329.
117. Saarela, M., Lahteenmaki, L., Crittenden, R., Salminen, S., Mattila-Sandholm, T., Gut bacteria and health foods—The European perspective. International Journal of Food Microbiology 2002, 78(1-2), 99-117.
118. Loftus, E. V., Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004, 126(6), 1504-1517.
119. Osman, N., Adawi, D., Ahrne, S., Jeppsson, B., Molin, G., Modulation of the effect of dextran sulfate sodium-induced acute colitis by the administration of different probiotic strains of Lactobacillus and Bifidobacterium. Digestive Diseases and Sciences 2004,49(2), 320-327.
120. Fabia, R., Arrajab, A., Johansson, M. L., Willen, R., Andersson, R., Molin, G., Bengmark, S., The effect of exogenous administration of Lactobacillus-Reuteri R2lc and oat fiber on acetic acid-induced colitis in the rat. Scandinavian Journal of Gastroenterology 1993, 28(2), 155-162.
121. Gionchetti, P., Rizzello, F., Venturi, A., Brigidi, P., Matteuzzi, D., Bazzocchi, G., Poggioli, G., Miglioli, M., Campieri, M., Oral bacteriotherapy as maintenance treatment in patientswith chronic pouchitis: A double-blind, placebo-controlled trial. Gastroenterology 2000, 119(2), 305-309.
122. Kruis, W., Fric, P., Pokrotnieks, J., Lukas, M., Fixa, B., Kascak, M., Kamm, M. A. et al., Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004, 53(11), 1617-1623.
123. Rembacken, B. J., Snelling, A. M., Hawkey, P. M., Chalmers, D. M., Axon, A. T. R., Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomised trial. Lancet 1999, 354(9179), 635-639.
124. Cashman, K. D., Shanahan, F., Is nutrition an aetiological factor for inflammatory bowel disease? European Journal of Gastroenterology & Hepatology 2003,15(6), 607-613.
125. Kato, K., Mizuno, S., Umesaki, Y., Ishii, Y., Sugitani, M., Imaoka, A., Otsuka, M. et al., Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Alimentary Pharmacology & Therapeutics 2004, 20(10), 1133-1141.
126. D'Souza, A. L., Rajkumar, C., Cooke, J., Bulpitt, C. J., Probiotics in prevention of antibiotic associated diarrhoea: Meta-analysis. British Medical Journal 2002, 324(7350), 1361-1364.
127. Nobaek, S., Johansson, M. L., Molin, G., Ahrne, S., Jeppsson, B., Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. American Journal of Gastroenterology2000, 95(5), 1231-1238.
128. Verdu, E. F., Collins, S. M., Irritable bowel syndrome. Best Practice & Research in Clinical Gastroenterology 2004,18(2), 315-321.
129. Sen, S., Mullan, M. M., Parker, T. J., Woolner, J. T., Tarry, S. A., Hunter, J. O., Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Digestive Diseases and Sciences 2002,47(11), 2615-2620.
130. Niedzielin, K., Kordecki, H., Birkenfeld, B., A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. European Journal of Gastroenterology & Hepatology 2001, 13(10), 1143-1147.
131. Halpern, G. M., Prindiville, T., Blankenburg, M., Hsia, T., Gershwin, M. E., Treatment of irritable bowel syndrome with Lacteol Fort: A randomized, double-blind, cross-over trial. American Journal of Gastroenterology 1996, 91(8), 1579-1585.
132. Bausserman, M., Michail, S., The use of Lactobacillus GG in irritable bowel syndrome in children: A double-blind randomized control trial. Journal of Pediatrics2005, 147(2), 197-201.
133. Callanan, M., Mining the probiotic genome: Advanced strategies, enhanced benefits, perceived obstacles. Current Pharmaceutical Design 2005,11(1), 25-36.
134. Hart, A. L., Stagg, A. J., Frame, M., Graffner, H., Glise, H., Falk, P., Kamm, M. A., Review article: The role of the gut flora in health and disease, and its modification as therapy. Alimentary Pharmacology & Therapeutics 2002, 16(8), 1383-1393.
135. Vanderhoof, J. A., Probiotics: Future directions. American Journal of Clinical Nutrition 2001, 73(6), 1152S-1155S.